News

Patients with type 2 diabetes mellitus are at a higher risk of developing heart failure compared with the healthy population. In recent landmark clinical trials, sodium-glucose co-transporter 2 (SGLT2 ...
Sodium alginate is a natural polysaccharide, which consists of abundant hydroxyl and carboxyl groups, has been widely reported as the raw material for the adsorption of heavy metals from aq. solns. ..
Algorithm to manage warfarin drug-drug interactions during warfarin initiation as well as adding a potentially interacting drug on chronic warfarin therapy. AP indicates antiplatelet; ... Interaction ...
Bristol-Myers makes an $11 billion deal with BioNTech to join the new cancer-treatment game, nearly double the size of Pfizer’s deal announced two weeks earlier.
You really can stop paying $4 a box for cereal because excellent generic options are typically 30% cheaper. In several blind test studies, kids who were given name-brand and generic cereals could ...
The sodium load from intravenous drug diluents significantly contributes to ICU-acquired hypernatraemia, with drug infusions comprising about 30% of the daily fluid volume of an average ICU patient.
Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia ...
Avadel Pharmaceuticals Receives Orphan Drug Designation From FDA For LUMRYZTM (Sodium Oxybate) For Extended-Release Oral Suspension For The Treatment Of Idiopathic Hypersomnia Date 2025-06-05 07:31:11 ...
But like every drug, they have their possible trade-offs, including muscle loss. The Truth About Ozempic and Muscle Loss Experts have correctly argued that this side effect isn’t truly unique to ...
Biocon has secured Indian regulatory approval for its generic Liraglutide drug substance and product, a version of Victoza, for treating Type 2 Diabetes in adults and children over 10. CEO Siddharth ...
Love Is a Drug. A.I. Chatbots Are Exploiting That. June 3, 2025. Credit... Somnath Bhatt. Listen to this article · 8:07 min Learn more. Share full article. 54. By Maia Szalavitz.
Rigorous answers about the program’s effects on drug innovation are still a ways off. However, some information about possible changes in beneficiary access is starting to trickle in as we ...